NIH vitamin methodology meeting
This article was originally published in The Tan Sheet
The National Institutes of Health's Office of Dietary Supplements will host a Vitamin Methodology Workshop July 7-8 in furtherance of a 2002 congressional mandate for NIH to speed up development of validated analytical methods and reference materials for commonly used botanicals and supplements. ODS conducted a public meeting in 2002 to design a strategy for implementing the congressional mandate, and a stakeholder meeting in September 2007 to provide updates on the program and solicit comments on its future. The upcoming meeting, which will review recommendations issued at the stakeholder meeting, will be at the Marriott Gaithersburg Washington Center Hotel in Gaithersburg, Md. Seating is limited, and registration is requested...
You may also be interested in...
Roche/Genentech oncology partnering maintained a robust dealmaking pace through the pandemic, keeping the percentage of partnered R&D programs at about 50% of the cancer drug pipeline.
To mitigate pandemic disruption of component supply chains, the US FDA said it will downgrade some post-approval change categories for sterile drug container closure systems. The downgrade will cover drugs in shortage and those used to treat COVID-19.
“This is truly uncharted territory because we’ve never had this situation,” says CHPA regulatory VP David Spangle. Asking Congress instead to instruct FDA to first determine a safe daily limit would be a threatening precedent for the supplement market, says CRN CEO Steve Mister. “That really turns DSHEA on its head.”